Tristan Chabanis

Tristan Chabanis serves as the Executive Vice President of the Pharmaceutical Division at SEQENS since September 2012, where responsibilities include leading Commercial, Marketing, R&D, and Project Management teams. Previously, Tristan held the position of Managing Director for the Innovative Pharmaceuticals (CDMO) Business Unit, overseeing a portfolio that included drug substances and small molecules across five manufacturing sites in Europe and the USA, with full P&L and cash-flow ownership managing approximately €100 million in sales. Additional experience includes serving as Group FP&A Director and Head of M&A, along with roles at Societe Generale Corporate and Investment Banking in private equity and credit analysis. Tristan holds a Diplôme d'Etudes Supérieures en Management, Finance d'entreprise from Grenoble Ecole de Management and a Master's degree in International Business from Grenoble Graduate School of Business.